Vaccination site pain; Sneezing; Rhinorrhea; generalized pruritis/itchy all over; local swelling and prutitis at site of injection s; local swelling and prutitis at site of injection s; vaccination site inflammation; bitter taste on my tongue; Erythema; swelling at injection site; This spontaneous case was reported by a physician and describes the occurrence of DYSGEUSIA (bitter taste on my tongue), ERYTHEMA (Erythema), VACCINATION SITE SWELLING (swelling at injection site), SNEEZING (Sneezing) and RHINORRHOEA (Rhinorrhea) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dystonia (localized dystonia of left leg) on 09-Jan-2008. Concurrent medical conditions included Drug allergy (allergic to sulfa drugs), Food allergy (allergic to mamey fruit) and Fish allergy (Allergic to shellfish).   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Dec-2020, the patient experienced DYSGEUSIA (bitter taste on my tongue), ERYTHEMA (Erythema) and VACCINATION SITE SWELLING (swelling at injection site). On 06-Jan-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Rhinorrhea), PRURITUS (generalized pruritis/itchy all over), VACCINATION SITE PRURITUS (local swelling and prutitis at site of injection s), VACCINATION SITE SWELLING (local swelling and prutitis at site of injection s) and VACCINATION SITE INFLAMMATION (vaccination site inflammation). On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). The patient was treated with LORATADINE for Allergic reaction, at a dose of 1 dosage form. At the time of the report, DYSGEUSIA (bitter taste on my tongue), ERYTHEMA (Erythema), VACCINATION SITE SWELLING (swelling at injection site), SNEEZING (Sneezing) and PRURITUS (generalized pruritis/itchy all over) outcome was unknown and RHINORRHOEA (Rhinorrhea), VACCINATION SITE PRURITUS (local swelling and prutitis at site of injection s), VACCINATION SITE SWELLING (local swelling and prutitis at site of injection s) and VACCINATION SITE INFLAMMATION (vaccination site inflammation) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. Patient took BOTOX Injection from past 3 years   Most recent FOLLOW-UP information incorporated above includes: On 23-Mar-2021: Patient details and event information is updated. On 21-May-2021: Follow up document is received on 21-MAY-2021 and it doesn't have any new information; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.